{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:25:18Z","timestamp":1787221518872,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,20]]},"DOI":"10.7759\/cureus.114838","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:48:16Z","timestamp":1787219296000},"source":"Crossref","is-referenced-by-count":0,"title":["A Greek Real-World Experience With the Implementation of the EndoPredict Gene Signature in a Cohort of Pre-menopausal and Post-menopausal Patients With ER+\/HER2- Breast Cancer"],"prefix":"10.7759","author":[{"given":"George","family":"Pantazidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antigoni","family":"Sourla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggeliki","family":"Vasiageorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Yfanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Alisandrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giasemi","family":"Stefanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggelos","family":"Petsavas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotini","family":"Pavlidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Styliani","family":"Parpoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Alexandrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sachoulidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annezo","family":"Marinatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Kalogridaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Kontoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis E","family":"Daskalakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlassios","family":"Tsantilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Chatzopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Kanistras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Argyriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Dragoumis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaia","family":"Stafyla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriana","family":"Kouloura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Galanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Papazoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Grosomanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Chatzopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Pasaskevakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Varnava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Giannopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenofon","family":"Xenakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Mpakogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Flessas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Nasikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Koronarchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios","family":"Douvetzemis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Fyssas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Spanopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimosthenis","family":"Baltas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Keramopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Bouloukos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilma","family":"Gaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysios T","family":"Dimas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis L","family":"Missitzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Rigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Kalyvopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Intzes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanos","family":"Zervoudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Europi","family":"Michailidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Katsourakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markos","family":"Thanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Zavos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Boutsikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kanara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios \u0391","family":"Rousogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Charatsaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlos","family":"Lampropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarantos","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos P","family":"Solakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Askoxylakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Kakoulaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Sfakianakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Vrentzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Milonaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kyriasanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foivos","family":"Irakleidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodoniki","family":"Iosifidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-3112-6","article-title":"Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage","volume":"147","author":"Chen L","year":"2014","unstructured":"Chen L, Linden HM, Anderson BO, Li CI. Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage. Breast Cancer Res Treat. 2014, 147:609-16. 10.1007\/s10549-014-3112-6","journal-title":"Breast Cancer Res Treat"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2016.0037","article-title":"Invasive Breast Cancer Version 1.2016, NCCN clinical practice guidelines in oncology","volume":"14","author":"Gradishar WJ","year":"2016","unstructured":"Gradishar WJ, Anderson BO, Balassanian R, et al.. Invasive Breast Cancer Version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016, 14:324-54. 10.6004\/jnccn.2016.0037","journal-title":"J Natl Compr Canc Netw"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-0619","article-title":"Clinical validation of EndoPredict in pre-menopausal women with ER-positive, HER2-negative primary breast cancer","volume":"28","author":"Constantinidou A","year":"2022","unstructured":"Constantinidou A, Marcou Y, Toss MS, et al.. Clinical validation of EndoPredict in pre-menopausal women with ER-positive, HER2-negative primary breast cancer. Clin Cancer Res. 2022, 28:4435-43. 10.1158\/1078-0432.CCR-22-0619","journal-title":"Clin Cancer Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17091482","article-title":"Gene expression signatures for guiding initial therapy in ER+\/HER2- early breast cancer","volume":"17","author":"Mar\u00edn-Li\u00e9bana S","year":"2025","unstructured":"Mar\u00edn-Li\u00e9bana S, Llor P, Serrano-Garc\u00eda L, et al.. Gene expression signatures for guiding initial therapy in ER+\/HER2- early breast cancer. Cancers (Basel). 2025, 17:1482. 10.3390\/cancers17091482","journal-title":"Cancers (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0926","article-title":"A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors","volume":"17","author":"Filipits M","year":"2011","unstructured":"Filipits M, Rudas M, Jakesz R, et al.. A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. Clin Cancer Res. 2011, 17:6012-20. 10.1158\/1078-0432.CCR-11-0926","journal-title":"Clin Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw149","article-title":"Comparison of EndoPredict and EPclin with oncotype DX recurrence score for prediction of risk of distant recurrence after endocrine therapy","volume":"108","author":"Buus R","year":"2016","unstructured":"Buus R, Sestak I, Kronenwett R, et al.. Comparison of EndoPredict and EPclin with oncotype DX recurrence score for prediction of risk of distant recurrence after endocrine therapy. J Natl Cancer Inst. 2016, 108:djw149. 10.1093\/jnci\/djw149","journal-title":"J Natl Cancer Inst"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds334","article-title":"EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer","volume":"24","author":"Dubsky P","year":"2013","unstructured":"Dubsky P, Filipits M, Jakesz R, et al.. EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer. Ann Oncol. 2013, 24:640-7. 10.1093\/annonc\/mds334","journal-title":"Ann Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3642","article-title":"Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+\/HER2- breast cancer patients: results from the GEICAM 9906 trial","volume":"16","author":"Martin M","year":"2014","unstructured":"Martin M, Brase JC, Calvo L, et al.. Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+\/HER2- breast cancer patients: results from the GEICAM 9906 trial. Breast Cancer Res. 2014, 16:R38. 10.1186\/bcr3642","journal-title":"Breast Cancer Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl S","year":"2024","unstructured":"Loibl S, Andr\u00e9 F, Bachelot T, et al.. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024, 35:159-82. 10.1016\/j.annonc.2023.11.016","journal-title":"Ann Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.08.017","article-title":"Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023","volume":"34","author":"Curigliano G","year":"2023","unstructured":"Curigliano G, Burstein HJ, Gnant M, et al.. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023. Ann Oncol. 2023, 34:970-86. 10.1016\/j.annonc.2023.08.017","journal-title":"Ann Oncol"},{"key":"ref13","article-title":"AJCC Cancer Staging Manual, 8th ed","year":"2017","unstructured":"AJCC Cancer Staging Manual, 8th ed. Amin MB, Edge, SB Greene FL, et al. (ed). Springer Nature, 2017."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0035","article-title":"Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Gradishar WJ","year":"2024","unstructured":"Gradishar WJ, Moran MS, Abraham J, et al.. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024, 22:331-57. 10.6004\/jnccn.2024.0035","journal-title":"J Natl Compr Canc Netw"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3310\/KGFD4040","article-title":"Tumour profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer: a systematic review and economic evaluation","volume":"29","author":"Tappenden P","year":"2025","unstructured":"Tappenden P, Cooper K, Hamilton J, et al.. Tumour profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer: a systematic review and economic evaluation. Health Technol Assess. 2025, 29:1-158. 10.3310\/KGFD4040","journal-title":"Health Technol Assess"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0376","article-title":"Prediction of distant recurrence using EndoPredict among women with ER(+), HER2(-) node-positive and node-negative breast cancer treated with endocrine therapy only","volume":"25","author":"Filipits M","year":"2019","unstructured":"Filipits M, Dubsky P, Rudas M, et al.. Prediction of distant recurrence using EndoPredict among women with ER(+), HER2(-) node-positive and node-negative breast cancer treated with endocrine therapy only. Clin Cancer Res. 2019, 25:3865-72. 10.1158\/1078-0432.CCR-19-0376","journal-title":"Clin Cancer Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-019-05226-8","article-title":"Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone","volume":"176","author":"Sestak I","year":"2019","unstructured":"Sestak I, Mart\u00edn M, Dubsky P, et al.. Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone. Breast Cancer Res Treat. 2019, 176:377-86. 10.1007\/s10549-019-05226-8","journal-title":"Breast Cancer Res Treat"},{"key":"ref18","article-title":"TNM classification","author":"Rosen RD","year":"2023","unstructured":"Rosen RD, Sapra A. TNM classification. StatPearls. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-024-07346-2","article-title":"Long-term prospective outcome data using EndoPredict as risk stratification and chemotherapy decision biomarker in hormone receptor-positive, HER2-negative early breast cancer","volume":"207","author":"Klein E","year":"2024","unstructured":"Klein E, Kiechle M, Josipovic A, et al.. Long-term prospective outcome data using EndoPredict as risk stratification and chemotherapy decision biomarker in hormone receptor-positive, HER2-negative early breast cancer. Breast Cancer Res Treat. 2024, 207:119-27. 10.1007\/s10549-024-07346-2","journal-title":"Breast Cancer Res Treat"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-020-05771-4","article-title":"First prospective outcome data for the second-generation multigene test Endopredict in ER-positive\/HER2-negative breast cancer","volume":"302","author":"Ettl J","year":"2020","unstructured":"Ettl J, Anders SI, Hapfelmeier A, et al.. First prospective outcome data for the second-generation multigene test Endopredict in ER-positive\/HER2-negative breast cancer. Arch Gynecol Obstet. 2020, 302:1461-7. 10.1007\/s00404-020-05771-4","journal-title":"Arch Gynecol Obstet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2025.104449","article-title":"Comparison of oncological outcomes of premenopausal with ovarian function suppression versus postmenopausal women in ER+\/HER2- breast cancer","volume":"81","author":"Lee MJ","year":"2025","unstructured":"Lee MJ, Jung JJ, Cheun JH, et al.. Comparison of oncological outcomes of premenopausal with ovarian function suppression versus postmenopausal women in ER+\/HER2- breast cancer. Breast. 2025, 81:104449. 10.1016\/j.breast.2025.104449","journal-title":"Breast"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103443","article-title":"Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial","volume":"9","author":"Penault-Llorca F","year":"2024","unstructured":"Penault-Llorca F, Dalenc F, Chabaud S, et al.. Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial. ESMO Open. 2024, 9:103443. 10.1016\/j.esmoop.2024.103443","journal-title":"ESMO Open"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1200\/PO.18.00361","article-title":"Predicting expected absolute chemotherapy treatment benefit in women with early-stage breast cancer using EndoPredict, an integrated 12-gene clinicomolecular assay","volume":"3","author":"Soliman H","year":"2019","unstructured":"Soliman H, Flake DD 2nd, Magliocco A, et al.. Predicting expected absolute chemotherapy treatment benefit in women with early-stage breast cancer using EndoPredict, an integrated 12-gene clinicomolecular assay. JCO Precis Oncol. 2019, 3:PO.18.00361. 10.1200\/PO.18.00361","journal-title":"JCO Precis Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/493012-a-greek-real-world-experience-with-the-implementation-of-the-endopredict-gene-signature-in-a-cohort-of-pre-menopausal-and-post-menopausal-patients-with-erher2--breast-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:48:17Z","timestamp":1787219297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/493012-a-greek-real-world-experience-with-the-implementation-of-the-endopredict-gene-signature-in-a-cohort-of-pre-menopausal-and-post-menopausal-patients-with-erher2--breast-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.114838","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}